Harvard Bioscience, Inc. (HBIO) Reports Q1 EPS of $0.09; Guides Q2
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.20 --0%
EPS Growth %: -800.0%
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
FIZZ, BNED, AOUT, More
EPS Growth %: -800.0%
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
FIZZ, BNED, AOUT, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q1 EPS of $0.09, versus $0.08 reported last year. Revenue for the quarter came in at $28.3 million, versus $26.3 million reported last year.
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Harvard Bioscience, Inc. sees Q2 2012 EPS of $0.06-$0.06. Harvard Bioscience, Inc. sees Q2 2012 revenue of $28-$29 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Barrick Mining said to delay IPO of American gold business to 2027
- Broadcom shares fall 3% after revenue forecast misses estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
